Skip to main content

and
  1. Article

    Open Access

    Safety and efficacy of terlipressin in acute-on-chronic liver failure with hepatorenal syndrome-acute kidney injury (HRS-AKI): a prospective cohort study

    Terlipressin with albumin, the recommended treatment for hepatorenal syndrome-acute kidney injury (HRS-AKI), is associated with adverse events. Furthermore, the course of AKI in patients with acute-on-chronic ...

    Anand V. Kulkarni, Sowmya Tirumalige Ravikumar, Harshvardhan Tevethia in Scientific Reports (2022)